Millennium Management’s Barinthus Biotherapeutics BRNS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-10,960
| Closed | -$13.2K | – | 3992 |
|
2024
Q4 | $13.2K | Buy |
10,960
+812
| +8% | +$974 | ﹤0.01% | 4003 |
|
2024
Q3 | $12.5K | Buy |
+10,148
| New | +$12.5K | ﹤0.01% | 4015 |
|
2023
Q2 | – | Sell |
-41,945
| Closed | -$94K | – | 4255 |
|
2023
Q1 | $94K | Buy |
41,945
+1,557
| +4% | +$3.49K | ﹤0.01% | 4075 |
|
2022
Q4 | $97K | Buy |
40,388
+9,967
| +33% | +$23.9K | ﹤0.01% | 4312 |
|
2022
Q3 | $96K | Sell |
30,421
-30,974
| -50% | -$97.7K | ﹤0.01% | 4708 |
|
2022
Q2 | $273K | Sell |
61,395
-7,261
| -11% | -$32.3K | ﹤0.01% | 4296 |
|
2022
Q1 | $357K | Sell |
68,656
-2,287
| -3% | -$11.9K | ﹤0.01% | 4300 |
|
2021
Q4 | $788K | Sell |
70,943
-47,333
| -40% | -$526K | ﹤0.01% | 3668 |
|
2021
Q3 | $1.86M | Sell |
118,276
-11,861
| -9% | -$187K | ﹤0.01% | 3109 |
|
2021
Q2 | $2.18M | Buy |
+130,137
| New | +$2.18M | ﹤0.01% | 3065 |
|